Advertisement

Topics

Investigational antibody boosts chemotherapy's cancer-killing potential

04:35 EDT 29 Jun 2017 | Pharmafile

A proof-of-concept study conducted at the Duke Cancer Institute (DCI) in North Carolina has shown that an investigational antibody has the ability to boost the cancer-killing effects of chemotherapy rituximab in those who have a natural resistance to it.

read more

Original Article: Investigational antibody boosts chemotherapy's cancer-killing potential

NEXT ARTICLE

More From BioPortfolio on "Investigational antibody boosts chemotherapy's cancer-killing potential"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...